Recent approaches in nanocarrier‐based therapies for neglected tropical diseases

AC Mengarda, B Iles, JPF Longo… - Wiley Interdisciplinary …, 2023 - Wiley Online Library
Neglected tropical diseases (NTDs) remain major public health problems in developing
countries. Reducing the burden of NTDs requires sustained collaborative drug discovery …

Pharmacological effects and underlying mechanisms of licorice‐derived flavonoids

Y Wu, Z Wang, Q Du, Z Zhu, T Chen… - Evidence‐Based …, 2022 - Wiley Online Library
Glycyrrhizae Radix et Rhizoma is the most frequently prescribed natural medicine in China
and has been used for more than 2,000 years. The flavonoids of licorice have garnered …

Licochalcone A: a review of its pharmacology activities and molecular mechanisms

M Liu, Y Du, D Gao - Frontiers in Pharmacology, 2024 - frontiersin.org
Licorice, derived from the root of Glycyrrhiza uralensis Fisch, is a key Traditional Chinese
Medicine known for its detoxifying, spleen-nourishing, and qi-replenishing properties …

Licochalcone A, a licorice flavonoid: Antioxidant, cytotoxic, genotoxic, and chemopreventive potential

KS de Freitas, IS Squarisi, NO Acesio… - Journal of Toxicology …, 2020 - Taylor & Francis
Licochalcone A (LicoA) is a flavonoid derived from Glycyrrhiza spp. plants. The present
study aimed to investigate the antioxidant, cytotoxic, genotoxic, and chemopreventive effects …

Neolignans isolated from Saururus cernuus L. (Saururaceae) exhibit efficacy against Schistosoma mansoni

JR Brito, P Wilairatana, DB Roquini, BC Parra… - Scientific Reports, 2022 - nature.com
Schistosomiasis, a parasitic disease caused by the blood fluke of the genus Schistosoma,
affects over 230 million people, especially in developing countries. Despite the significant …

Licochalcone A-Loaded Solid Lipid Nanoparticles Improve Antischistosomal Activity In Vitro and In Vivo

LM Silva, DG Marconato, MP Nascimento da Silva… - …, 2021 - Taylor & Francis
Aim: To isolate licochalcone A (LicoA) from licorice, prepare LicoA-loaded solid lipid
nanoparticles (L-SLNs) and evaluate the L-SLNs in vitro and in vivo against Schistosoma …

In silico inhibition of SGTP4 as a therapeutic target for the treatment of schistosomiasis

TA Adekiya, RT Aruleba, A Klein… - Journal of Biomolecular …, 2022 - Taylor & Francis
Schistosomiasis is an infectious tropical disease caused by parasitic flatworm of the genus
Schistosoma. This debilitating disease chronically infects about 200 million people globally …

[HTML][HTML] Combination therapy and phytochemical-loaded nanosytems for the treatment of neglected tropical diseases

J Soto-Sánchez, G Garza-Treviño - Pharmaceutics, 2024 - mdpi.com
Background: Neglected tropical diseases (NTDs), including leishmaniasis, trypanosomiasis,
and schistosomiasis, impose a significant public health burden, especially in developing …

[HTML][HTML] Schistosomicidal activity of kaurane, labdane and clerodane-type diterpenes obtained by fungal transformation

LC Oliveira, TS Porto, AHC Junior, MFC Santos… - Process …, 2020 - Elsevier
Schistosomiasis continues to be a huge challenge for researchers, pharmaceutical
companies, and governments in developing countries. Diterpene compounds are good …

Therapeutic Potential of Natural Products in the Treatment of Schistosomiasis

CM Azevedo, CS Meira, JW da Silva, DMN Moura… - Molecules, 2023 - mdpi.com
It is estimated that 250 million people worldwide are affected by schistosomiasis. Disease
transmission is related to the poor sanitation and hygiene habits that affect residents of …